Which antipsychotics should we consider selecting as the first-line and second-line treatments, and what should we base this decision on? Dr. Aziz addresses this in a past article from The Carlat Psychiatry Report. Here’s some of his advice:Process: Tolerability instead of efficacy should be considered when selecting a first-line treatment.

Lithium takes on the coronavirus. Benzos impair facial recognition. Antipsychotic doses find their maximum, the profile of a lithium responder, and topiramate for compulsive shopping.Published On: 4/21/20Duration: 13 minutes, 51 secondsStudies Referenced: Garcez H, Fernandes C, Barbosa F, et al. Effects of benzodiazepines administration on identification of facial expressions of...

We're supposed to move to clozapine after two failed antipsychotics in schizophrenia, but how many of us are really doing that?  Not enough. Clozapine may be difficult to use, but it is life changing for many patients. Here we bring you 7 tips, from serum plasma levels to little-known side...

Some antidepressants get better as the dose goes higher, while others just fizzle. For older patients, the side effects stack up as the benefits plateau. We review 3 new meta-analyses on antidepressant dosing, and bring you 4 updates on how the coronavirus is changing practice regulation.Date Published: 3/30/2020Duration: 27 minutes,...

Oxcarbazepine is thought of as a kinder, gentler cousin of carbamazepine, but it brings new safety issues of its own and does not fully escape the drug interactions that hinder carbamazepine. We pull on the published and unpublished trials to figure out where this anticonvulsant stands in bipolar disorder.